Cervical dysplasias 1982–2010 in the Republic of Panama. Diagnosis, treatment, and evolution

The aim of this work was to demonstrate the effectiveness of colposcopic diagnosis and conservative local treatments in cases of dysplasia after colpocytology and directed biopsy. The main treatments applied were cryosurgery and cauterization. The association of dysplasia and human papillomavirus (HPV) showed an increase of 96% in recent years. The local destructive treatments (TLC), in addition to destroy the virus, have also successfully activated the local immunological system mechanism against HPV. The evidence of such affirmation is based on the obtained results that are: 76% cured, 11% improved, 6.8% persistent, 3.4% recurrence, and only one percent progression.

Dysplasia; Diagnosis; Management; Evolution.

[1] Garrido J.L.: “Estudio de la incidencia patológica de la displasia en algunas áreas de la República de Panamá durante el periodo 1982.1985”. Clinica Ginecólogica, 1989, 20, 2.

[2] Garrido J.L.: “Displasias”. Clinica Ginecólogica, 1993, 14, 2.

[3] Garrido M.J.: “Comparative findings of oncogenic cervical risk and its follow-up in two different periods 1982-1999 and 2000-2007“. Eur. J. Gynaecol. Oncol., 2010, 31, 559.

[4] Dexeus S.: “CIN treatments”. Eur. J. Gynaecol. Oncol., 1983, 20, 215.

[5] Agnantis N.J., Sotiriadis A., Paraskevaidis E.: “The current status of HPV DNA testing”. Eur. J. Gynaecol. Oncol., 2003, 24, 351.

[6] Deligeoroglou E., Christopoulos P., Aravantinos L., Papadias K.: “Human papilloma virus molecular profile and mechanisms of cancerogenesis: a review”. Eur. J. Gynaecol. Oncol., 2009, 30, 128.

[7] Machado F.A., Janssens J.P., Michelin M.A., Murta E.F.: “Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix“. Clin. Exp. Obstet. Gynecol., 2012, 39, 27.

[8] Ramos M.C., Pizarro De Lorenzo B.H., Michelin M.A., Murta E.F.: “High-grade cervical intraepithelial neoplasia, human papillomavirus and factors connected with recurrence following surgical treatment“. Clin. Exp. Obstet. Gynecol., 2008, 35, 242.

[9] Bosze P.: “Management of cytological findings”. Eur. J. Gynaecol. Oncol., 2010, 21, 3.

[10] Garrido Martínez JL, Díaz MM, Villarreal A.: “Twenty years of contributions to the study and prevention of uterine cancer“. Eur. J. Gynaecol. Oncol., 2006, 27, 600.

[11] Bosze P.: “Colposcopy used in a primary setting (routine colposcopy): advantages and concerns“. Eur. J. Gynaecol. Oncol., 2006, 27, 5.